-
Featured
Favipiravir to Treat COVID-19: Q&A with Boris Juelg, MD, PhD
Boris Juelg, MD, PhD, an attending physician in the Division of Infectious Diseases at Massachusetts General Hospital and an assistant professor at Harvard Medical School, explains what is currently known about the drug favipiravir and why he is excited about its potential to treat COVID-19 patients.
-
Featured
Prone Positioning May Benefit Non-Intubated Patients with Severe COVID-19
Management of acute respiratory distress syndrome (ARDS) related to COVID-19 should prioritize lung-protective ventilation, but prone positioning may benefit patients with COVID-19 and hypoxemia who are not intubated.
-
Featured
Using Chloroquine to Treat COVID-19: Q&A with Raghu Chivukula, MD, PhD
Raghu Chivukula, MD, PhD, a physician-scientist in the Division of Pulmonary and Critical Care Medicine at Massachusetts General Hospital, explains what is currently known about chloroquine and its use to treat COVID-19 patients.
-
Blood Type Does Not Affect Risk of COVID-19 or COVID-19 Mortality
When survivors of COVID-19 were compared with non-survivors in China or the U.S., there was no association between ABO blood group and fatal outcome.
-
Bowel Necrosis in a Patient with COVID-19
Massachusetts General Hospital surgeons have described a critically ill patient with COVID-19 who developed catastrophic bowel necrosis despite widely patent mesenteric vessels.
-
Is There a Connection Between Blood Type and COVID-19? Q&A with Rebecca Karp Leaf, MD, and Hanny Al-Samkari, MD
In this Q&A, Rebecca Karp Leaf, MD, and Hanny Al-Samkari, MD, of Massachusetts General Hospital, give us a rundown of what is known to date about the correlation between blood type and COVID-19 transmission/severity, findings from their study and why this connection may or may not exist.
COVID-19 contributors
-
Boris D. Juelg, MD, PhD
Attending Physician, Division of Infectious Diseases, Massachusetts General Hospital, Assistant Professor, Harvard Medical School
Recent Article
Favipiravir to Treat COVID-19: Q&A with Boris Juelg, MD, PhD
-
Bryan Hayes, PharmD, DABAT, FAACT, FASHP
Assistant Professor of Emergency Medicine, Harvard Medical School, Senior Attending Pharmacist, Emergency Medicine and Toxicology, Massachusetts General Hospital
Recent Article
The Use of NSAIDs in COVID-19 Patients: Q&A with Bryan D. Hayes, PharmD -
Charles Corey Hardin, MD, PhD
Physician, Division of Pulmonary and Critical Care Medicine, Massachusetts General Hospital, Associate Professor of Medicine, Harvard Medical School, Physician Investigator, Pulmonary, Mass General Research Institute
Recent Article
No Evidence to Support Novel Mechanism of Hypoxemia in COVID-19
-
Elizabeth Louise Hohmann, MD
Staff Physician, Infectious Diseases Division, Massachusetts General Hospital, Chair and Physician Director, Partners Human Research Committees
Recent Article
Encapsulated Fecal Microbiota Transplantation Alters Gut Microbiome in Adults with Obesity -
Katrina A. Armstrong, MD
Physician-in-Chief, Department of Medicine, Massachusetts General Hospital
Recent Article
Medical Grand Rounds: COVID-19 Patient Recovery and Rehab
-
Louise C. Ivers, MD
Executive Director of the Mass General Center for Global Health, Associate Physician in the Division of Infectious Diseases
Recent Article
Medical Grand Rounds: COVID-19 in Low-Resourced Settings—Reaching for Global Health Equity -
Raghu Chivukula, MD, PhD
Physician-Scientist, Division of Pulmonary and Critical Care Medicine, Massachusetts General Hospital
Recent Article
Identification of Novel Bronchiectasis Syndrome Has Implications for Other Respiratory Diseases
